MA
ARKG icon

Mutual Advisors’s ARK Genomic Revolution ETF ARKG Stock Holding History

Mutual Advisors’s Portfolio ARKG Stock Details ARKG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$313K Buy
+7,431
New +$237K 0.01% 1159
2026
Q1 		– Sell
-7,651
Closed -$222K – 1332
2025
Q4 		$222K Buy
7,651
+100
+1% +$3K ﹤0.01% 1220
2025
Q3 		$237K Sell
7,551
-157
-2% -$3.97K 0.01% 1154
2025
Q2 		$200K Buy
+7,708
New +$169K 0.01% 1132
2025
Q1 		– Sell
-38,376
Closed -$931K – 1085
2024
Q4 		$931K Sell
38,376
-2,084
-5% -$51.3K 0.03% 500
2024
Q3 		$942K Sell
40,460
-763
-2% -$19.4K 0.03% 498
2024
Q2 		$1.11M Sell
41,223
-948
-2% -$23.9K 0.03% 452
2024
Q1 		$1.21M Sell
42,171
-618
-1% -$18.6K 0.04% 422
2023
Q4 		$1.4M Sell
42,789
-865
-2% -$23.5K 0.05% 355
2023
Q3 		$1.22M Buy
43,654
+1,257
+3% +$41.1K 0.05% 369
2023
Q2 		$1.45M Buy
42,397
+361
+0.9% +$11.3K 0.05% 332
2023
Q1 		$1.26M Buy
42,036
+820
+2% +$25.4K 0.05% 356
2022
Q4 		$1.16M Sell
41,216
-7,301
-15% -$232K 0.05% 371
2022
Q3 		$1.59M Buy
48,517
+137
+0.3% +$5.03K 0.08% 240
2022
Q2 		$1.52M Sell
48,380
-3,090
-6% -$108K 0.1% 238
2022
Q1 		$2.36M Buy
51,470
+3,775
+8% +$180K 0.13% 182
2021
Q4 		$2.92M Buy
47,695
+7,531
+19% +$521K 0.15% 156
2021
Q3 		$3M Buy
40,164
+4,563
+13% +$383K 0.18% 139
2021
Q2 		$3.29M Buy
35,601
+14,908
+72% +$1.27M 0.2% 130
2021
Q1 		$1.84M Sell
20,693
-2,375
-10% -$236K 0.13% 206
2020
Q4 		$2.15M Buy
23,068
+1,341
+6% +$107K 0.16% 149
2020
Q3 		$1.38M Buy
+21,727
New +$1.27M 0.12% 187

Other funds holding ARKG

JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
JFG
Jefferies Financial Group New York $15.2B AUM 55.75% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
State of Wisconsin Investment Board
State of Wisconsin Investment Board Madison, Wisconsin $49.6B AUM 39.59% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Mutual Advisors's ARKG Position: Q2 2026 in Review

Mutual Advisors opened a new position in ARK Genomic Revolution ETF (ARKG) in Q2 2026: 7,431 shares worth $313K. The stake represents 0.01% of the portfolio and ranks #1159 among its holdings. This is a return to the name: Mutual Advisors previously reported a position in ARKG as recently as Q4 2025.

Mutual Advisors first reported a position in ARKG in Q3 2020 and has held it in 22 quarters since. The position peaked at $3.29M in Q2 2021. 272 funds tracked by Wall St. Rank hold ARKG as of Q2 2026.

  • Mutual Advisors held 7,431 shares of ARK Genomic Revolution ETF worth $313K as of Q2 2026.
  • ARK Genomic Revolution ETF was a new Mutual Advisors position in Q2 2026.
  • ARK Genomic Revolution ETF made up 0.01% of Mutual Advisors's portfolio in Q2 2026, its #1159 holding.
  • Mutual Advisors first reported a position in ARK Genomic Revolution ETF in Q3 2020 and has held it in 22 quarters since.
  • Mutual Advisors's ARK Genomic Revolution ETF position peaked at $3.29M in Q2 2021.
  • 272 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q2 2026.

Based on Mutual Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.